AboTA
News
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This milestone is a strong reflection of Merck’s progress in biosimilars, with the goal of delivering high-quality biologics to patients all over the world. “With the […]
08.10.2018
Food activates brown fat
Brown fat consumes energy, which is the reason why it could be important for preventing obesity and diabetes. Working together with an international team, researchers at the Technical University of Munich (TUM) were able to demonstrate that food also increases the thermogenesis of brown fat, and not just cold as previously assumed. Brown […]
15.06.2017
Syneron Candela’s PicoWay picosecond laser now with three wavelengths and resolve fractional
PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for a new ultra-short 785 nm wavelength, making it the third FDA cleared wavelength for PicoWay. The new ultra-short 785nm wavelength is the first of its kind in the aesthetic market, utilizing a titanium sapphire laser for the removal of blue and green inks. […]